CHD005
The percentage of patients with coronary heart disease with a record in the preceding 12 months that aspirin, an alternative anti-platelet therapy, or an anti-coagulant is being taken
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CHD 9 | 2011 | 14763 | 15707 | 94.0% | |
| CHD 9 | 2012 | 14829 | 15853 | 93.5% | |
| CHD 9 | 2013 | 14670 | 15689 | 93.5% | |
| CHD005 | 2014 | 14823 | 15335 | 96.7% | |
| CHD005 | 2015 | 14737 | 15258 | 96.6% | |
| CHD005 | 2016 | 14938 | 15433 | 96.8% | |
| CHD005 | 2017 | 15085 | 15522 | 97.2% | |
| CHD005 | 2018 | 15187 | 15697 | 96.8% | |
| CHD005 | 2019 | 15444 | 15981 | 96.6% | |
| CHD005 | 2020 | 15523 | 16315 | 95.1% | |
| CHD005 | 2021 | 15055 | 16791 | 89.7% | |
| CHD005 | 2022 | 15754 | 16509 | 95.4% | |
| CHD005 | 2023 | 15939 | 16679 | 95.6% |
